CoChat
Sign Up
Cited by 201

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer’s disease

LIU, CHEN-GENG, SONG, JING, ZHANG, YUE-QI, WANG, PEI-CHANG·2014·Molecular Medicine Reports
DOI 10.3892/mmr.2014.2484
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/mmr.2014.2484

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 4 references

Research works printed but not linked: 26

  1. Lewczuk, 2010, Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer’s disease: a multicenter study, Mol Psychiatry, 15, 138, 10.1038/mp.2008.84 · DOI
  2. Weiner, 2013, Dementia in 2012: Further insights into Alzheimer disease pathogenesis, Nat Rev Neurol, 2, 65, 10.1038/nrneurol.2012.275 · DOI
  3. Singer, 2005, Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model, Nat Neurosci, 8, 1343, 10.1038/nn1531 · DOI
  4. Tan, 2013, Non-coding RNAs in Alzheimer’s disease, Mol Neurobiol, 47, 382, 10.1007/s12035-012-8359-5 · DOI
  5. Junn, 2012, MicroRNAs in neurodegenerative diseases and their therapeutic potential, Pharmacol Ther, 133, 142, 10.1016/j.pharmthera.2011.10.002 · DOI · Paper page
  6. Delay, 2012, MicroRNAs in Alzheimer’s disease, Neurobiol Dis, 46, 285, 10.1016/j.nbd.2012.01.003 · DOI · Paper page
  7. Long, 2011, MicroRNA-101 downregulates Alzheimer’s amyloid-β precursor protein levels in human cell cultures and is differentially expressed, Biochem Biophys Res Commun, 404, 889, 10.1016/j.bbrc.2010.12.053 · DOI
  8. Delay, 2011, Alzheimer-specific variants in the 3′UTR of Amyloid precursor protein affect microRNA function, Mol Neurodegener, 6, 70, 10.1186/1750-1326-6-70 · DOI
  9. Hébert, 2010, Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration, Hum Mol Genet, 19, 3959, 10.1093/hmg/ddq311 · DOI
  10. Rembach, 2014, AIBL research group, Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer’s disease, Alzheimers Dement, 10, 53, 10.1016/j.jalz.2012.12.006 · DOI
  11. Lewczuk, 2010, Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer’s disease: a multicenter study, Mol Psychiatry, 15, 138, 10.1038/mp.2008.84 · DOI
  12. Wang, 2011, Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter, Acta Neuropathol, 2, 193, 10.1007/s00401-010-0756-0 · DOI · Paper page
  13. Hosseini, 2013, The role of exosomes in infectious diseases, Inflamm Allergy Drug Targets, 1, 29, 10.2174/1871528111312010005 · DOI
  14. Pant, 2012, The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities, Biochem Pharmacol, 11, 1484, 10.1016/j.bcp.2011.12.037 · DOI
  15. Boon, 2013, Intercellular transport of microRNAs, Arterioscler Thromb Vasc Biol, 33, 186, 10.1161/ATVBAHA.112.300139 · DOI
  16. Wei, 2011, Matrix metalloproteinase-12 leads to elastin degradation in BALB/c mice with eosinophilic meningitis caused by Angiostrongylus cantonensis, Int J Parasitol, 41, 1175, 10.1016/j.ijpara.2011.07.002 · DOI
  17. Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1, J Neurosci, 5, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
  18. Liu, 2007, 17Beta-oestradiol regulates the expression of Na+/K+-ATPase beta1-subunit, sarcoplasmic reticulum Ca2+-ATPase and carbonic anhydrase iv in H9C2 cells, Clin Exp Pharmacol Physiol, 34, 998, 10.1111/j.1440-1681.2007.04675.x · DOI
  19. Dassow, 2013, MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy, Curr Pharm Des, 19, 1242
  20. Eulalio, 2012, The mammalian microRNA response to bacterial infections, RNA Biol, 9, 742, 10.4161/rna.20018 · DOI
  21. Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105 · DOI · Paper page
  22. Giedraitis, 2007, The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer’s disease, Neurosci Lett, 427, 127, 10.1016/j.neulet.2007.09.023 · DOI
  23. Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol, 4, 423, 10.1038/ncb2210 · DOI · Paper page
  24. van Leuven, 2000, Single and multiple transgenic mice as models for Alzheimer’s disease, Prog, Neurobiol, 61, 305
  25. Ceruti, 2011, Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier, Neurochem Int, 59, 259, 10.1016/j.neuint.2011.05.013 · DOI
  26. Ma, 2012, Circulating microRNAs in cancer: origin, function and application, J Exp Clin Cancer Res, 31, 38, 10.1186/1756-9966-31-38 · DOI

Cited by

Sorted by citations

See all 201

Metadata

Authors
LIU, C.-G., SONG, J., ZHANG, Y.-Q., & WANG, P.-C.
Venue
Molecular Medicine Reports
Publisher
Spandidos Publications
Published
2014-08-12
Volume
10
Issue
5
Pages
2395-2400
ISSN
  • 1791-2997
  • 1791-3004
DOI
10.3892/mmr.2014.2484
Cited by
201
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review